HPGC Renmintongtai Pharmaceutical (SHSE:600829) Net Change in Cash : ¥-287 Mil (TTM As of Mar. 2025)

View and export this data going back to 1994. Start your Free Trial

What is HPGC Renmintongtai Pharmaceutical Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

HPGC Renmintongtai Pharmaceutical's Net Change in Cash for the three months ended in Mar. 2025 was ¥-275 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 was ¥-287 Mil.

HPGC Renmintongtai Pharmaceutical Net Change in Cash Historical Data

The historical data trend for HPGC Renmintongtai Pharmaceutical's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPGC Renmintongtai Pharmaceutical Net Change in Cash Chart

HPGC Renmintongtai Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

49.61

97.76

450.97

270.99

-217.92

HPGC Renmintongtai Pharmaceutical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Change in Cash	Get a 7-Day Free Trial															-206.66	-21.11	-274.77	284.62	-275.33

HPGC Renmintongtai Pharmaceutical Net Change in Cash Calculation

HPGC Renmintongtai Pharmaceutical's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	115.436	+	-7.895	+	-325.464	+	0
	=	-218

HPGC Renmintongtai Pharmaceutical's Net Change in Cash for the quarter that ended in Mar. 2025

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -302.722 + -0.626 + 28.015 + 0

= -275

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-287 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HPGC Renmintongtai Pharmaceutical Net Change in Cash Related Terms
Thank you for viewing the detailed overview of HPGC Renmintongtai Pharmaceutical's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

HPGC Renmintongtai Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » Net Change in Cash

Comparable Companies

SHSE:600351 SHSE:603207 SZSE:002923 SZSE:000919 SHSE:688799 SHSE:600479 BJSE:832735 SZSE:002393 SZSE:300158 SZSE:300485 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA

Traded in Other Exchanges

N/A

Address

No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076

Website

http://www.sanjing.com.cn

HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.

Executives

Yue Xian Zhi senior management

Zhang Li Jun Director

HPGC Renmintongtai Pharmaceutical Headlines

No Headlines